{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:24:38Z","timestamp":1792243478860,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008126","name":"Jeju National University Hospital","doi-asserted-by":"publisher","award":["JRA\/Sep23\/002"],"award-info":[{"award-number":["JRA\/Sep23\/002"]}],"id":[{"id":"10.13039\/501100008126","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.esmoop.2025.104495","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T15:02:36Z","timestamp":1741618956000},"page":"104495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing"],"prefix":"10.1016","volume":"10","author":[{"given":"S.W.","family":"Cheo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.Y.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.G.W.","family":"Ow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.L.","family":"Ow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.H.J.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.J.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.A.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.-L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.esmoop.2025.104495_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000172","article-title":"Multiple primary tumours: challenges and approaches, a review","volume":"2","author":"Vogt","year":"2017","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.esmoop.2025.104495_bib2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12916-022-02535-6","article-title":"Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies","volume":"20","author":"Cavazos","year":"2022","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.esmoop.2025.104495_bib3","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.3390\/ijms24076705","article-title":"Genetic analysis of multiple primary malignant tumors in women with breast and ovarian cancer","volume":"24","author":"Savkova","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1093","key":"10.1016\/j.esmoop.2025.104495_bib4","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180390","article-title":"Review of risk factors of secondary cancers among cancer survivors","volume":"92","author":"Demoor-Goldschmidt","year":"2019","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.esmoop.2025.104495_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ejhg.2014.157","article-title":"A\u00a0clinical and genetic analysis of multiple primary cancer referrals to genetics services","volume":"23","author":"Whitworth","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"10.1016\/j.esmoop.2025.104495_bib6","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.3390\/diagnostics12081940","article-title":"Synchronous\/metachronous multiple primary malignancies: review of associated risk factors","volume":"12","author":"Pan","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.esmoop.2025.104495_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/CMAR.S57378","article-title":"Multiple neoplasms, single primaries, and patient survival","volume":"6","author":"Amer","year":"2014","journal-title":"Cancer Manag Res"},{"issue":"11","key":"10.1016\/j.esmoop.2025.104495_bib8","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.bjc.6603172","article-title":"Multiple primary tumours in women following breast cancer, 1973-2000","volume":"94","author":"Raymond","year":"2006","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.esmoop.2025.104495_bib9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1200\/JCO.2011.37.0239","article-title":"Variation of second cancer risk by family history of retinoblastoma among long-term survivors","volume":"30","author":"Kleinerman","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2025.104495_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ygyno.2004.09.039","article-title":"The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers","volume":"96","author":"Metcalfe","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2025.104495_bib11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jnci\/djs525","article-title":"Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome","volume":"105","author":"Win","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.esmoop.2025.104495_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"55","key":"10.1016\/j.esmoop.2025.104495_bib13","doi-asserted-by":"crossref","first-page":"30649","DOI":"10.18632\/oncotarget.25769","article-title":"Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers","volume":"9","author":"Chan","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.esmoop.2025.104495_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/1055-9965.EPI-21-0820","article-title":"Multiple primary cancers in patients undergoing tumor-normal sequencing define novel associations","volume":"31","author":"Liu","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.esmoop.2025.104495_bib15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jamaoncol.2017.3605","article-title":"Prevalence of prior cancer among persons newly diagnosed with cancer: an initial report from the surveillance, epidemiology, and end results program","volume":"4","author":"Murphy","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmoop.2025.104495_bib16","series-title":"National Registry of Diseases Office (NRDO).","article-title":"Singapore Cancer Registry Annual Report 2021.","author":"Singapore Cancer Registry, Health Promotion Board","year":"2023"},{"issue":"1","key":"10.1016\/j.esmoop.2025.104495_bib17","article-title":"Pattern of occurrence and management of dual malignancy: our institutional experience","volume":"9","author":"Singh","year":"2022","journal-title":"Rep Radiother Oncol"},{"issue":"24","key":"10.1016\/j.esmoop.2025.104495_bib18","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.3390\/cancers15245788","article-title":"Susceptibility genes associated with multiple primary cancers","volume":"15","author":"Lu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.esmoop.2025.104495_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.813457","article-title":"BRCA1 and breast cancer: molecular mechanisms and therapeutic strategies","volume":"10","author":"Fu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.esmoop.2025.104495_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.840431","article-title":"Common multiple primary cancers associated with breast and gynecologic cancers and their risk factors, pathogenesis, treatment and prognosis: a review","volume":"12","author":"Ge","year":"2022","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2025.104495_bib21","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/ijc.28988","article-title":"Multiple primary cancers as a guide to heritability","volume":"135","author":"Cybulski","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2025.104495_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajhg.2018.04.013","article-title":"Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes","volume":"103","author":"Whitworth","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.esmoop.2025.104495_bib23","first-page":"868","article-title":"CFTR and gastrointestinal cancers: an update","volume":"12","author":"Bhattacharya","year":"2022","journal-title":"J\u00a0Pers Med"},{"issue":"9","key":"10.1016\/j.esmoop.2025.104495_bib24","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.3390\/ijms21093133","article-title":"What role does CFTR play in development, differentiation, regeneration and cancer?","volume":"21","author":"Amaral","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.esmoop.2025.104495_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fgene.2020.00395","article-title":"Synchronous periampullary tumors in a patient with pancreas divisum and neurofibromatosis type 1","volume":"11","author":"Greg\u00f3rio","year":"2020","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.esmoop.2025.104495_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000348439","article-title":"Clinical and morphological characteristics of sporadic genetically determined pancreatitis as compared to idiopathic pancreatitis: higher risk of pancreatic cancer in CFTR variants","volume":"87","author":"Hamoir","year":"2013","journal-title":"Digestion"},{"issue":"7","key":"10.1016\/j.esmoop.2025.104495_bib27","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/ijc.33431","article-title":"Cystic fibrosis F508del carriers and cancer risk: results from the UK Biobank","volume":"148","author":"Shi","year":"2021","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2025.104495_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcf.2022.10.001","article-title":"The risk of colorectal cancer in individuals with mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene: an English population-based study","volume":"22","author":"Birch","year":"2023","journal-title":"J\u00a0Cyst Fibros"},{"issue":"3","key":"10.1016\/j.esmoop.2025.104495_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.GIM.0000127268.65149.69","article-title":"Cystic fibrosis screening: lessons learned from the first 320,000 patients","volume":"6","author":"Strom","year":"2004","journal-title":"Genet Med"},{"key":"10.1016\/j.esmoop.2025.104495_bib30","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1038\/s41598-024-57513-0","article-title":"Prevalence of common autosomal recessive mutation carriers in women in the Southern Vietnam following the application of expanded carrier screening","volume":"14","author":"To-Mai","year":"2024","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.esmoop.2025.104495_bib31","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.3390\/ijms22083814","article-title":"Functional roles of SPINK1 in cancers","volume":"22","author":"Lin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.esmoop.2025.104495_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fcell.2019.00010","article-title":"Bad tumors made worse: SPINK1","volume":"7","author":"Mehner","year":"2019","journal-title":"Front Cell Dev Biol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925003643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925003643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:43:59Z","timestamp":1762598639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702925003643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2059702925003643"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.104495","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.104495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"104495"}}